Efficacy and Safety of Alirocumab in Japanese Patients with Diabetes Mellitus: Post-hoc Subanalysis of ODYSSEY Japan

Aim: To examine the efficacy and safety of alirocumab in Japanese patients with dyslipidemia with or without diabetes mellitus (DM). Methods: Patients (n = 216) with heterozygous familial hypercholesterolemia (heFH), non-FH at high cardiovascular risk with coronary artery disease (CAD), or category...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:J Atheroscler Thromb
Asıl Yazarlar: Teramoto, Tamio, Usami, Makiko, Takagi, Yoshiharu, Baccara-Dinet, Marie T.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Japan Atherosclerosis Society 2019
Konular:
Original Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6402882/
https://ncbi.nlm.nih.gov/pubmed/30068817
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5551/jat.45070
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller